Comparing Efficacy and Safety of Bmab 1200 and Stelara in Patients With Moderate to Severe Chronic Plaque Psoriasis
Clinical trial NCT05335356 · COMPLETED
Trial details
- NCT number
- NCT05335356
- Sponsor
- Biocon Biologics UK Ltd
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-28
- Primary completion
- 2023-01-26
- Enrollment
- 384
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.